Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Colas

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Journal of Biology|February 8, 2008
The eleven-year switch of peptide aptamersPierre Colas
Orphanet Journal of Rare Diseases|August 9, 2020
Cyclin-dependent kinases and rare developmental disordersPierre Colas
Current Drug Discovery Technologies|August 12, 2008
High-throughput screening assays to discover small-molecule inhibitors of protein interactionsPierre Colas
Trends in Pharmacological Sciences|December 2, 2011
Yeast two-hybrid methods and their applications in drug discoveryAmel Hamdi, Pierre Colas
Drug Discovery Today|April 4, 2006
Peptide aptamers as guides for small-molecule drug discoveryIvan C Baines, Pierre Colas
Medecine Sciences : M/S|May 27, 2020
[Budding yeast, a model and a tool… also for biomedical research]Stéphane Bach, Pierre Colas, Marc Blondel
Oncotarget|June 29, 2011
Targeting cancer with peptide aptamersRenaud Seigneuric, Jessica Gobbo, Pierre Colas, et al.
Frontiers in Chemistry|May 14, 2026
Bulky PP1 analogs exert cellular effects independently from analog-sensitive kinase inhibitionCoralie Gicquel, Sabine Genicot, Arnaud Comte, et al.
Molecular Genetics & Genomic Medicine|August 9, 2021
Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disordersThomas Robert, Anne-Catherine Dock-Bregeon, Pierre Colas
Oncotarget|February 9, 2017
The awakening of the CDK10/Cyclin M protein kinaseVincent J Guen, Carly Gamble, Jacqueline A Lees, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Journal of Biology|February 8, 2008
The eleven-year switch of peptide aptamersPierre Colas
Orphanet Journal of Rare Diseases|August 9, 2020
Cyclin-dependent kinases and rare developmental disordersPierre Colas
Current Drug Discovery Technologies|August 12, 2008
High-throughput screening assays to discover small-molecule inhibitors of protein interactionsPierre Colas
Trends in Pharmacological Sciences|December 2, 2011
Yeast two-hybrid methods and their applications in drug discoveryAmel Hamdi, Pierre Colas
Drug Discovery Today|April 4, 2006
Peptide aptamers as guides for small-molecule drug discoveryIvan C Baines, Pierre Colas
Medecine Sciences : M/S|May 27, 2020
[Budding yeast, a model and a tool… also for biomedical research]Stéphane Bach, Pierre Colas, Marc Blondel
Oncotarget|June 29, 2011
Targeting cancer with peptide aptamersRenaud Seigneuric, Jessica Gobbo, Pierre Colas, et al.
Frontiers in Chemistry|May 14, 2026
Bulky PP1 analogs exert cellular effects independently from analog-sensitive kinase inhibitionCoralie Gicquel, Sabine Genicot, Arnaud Comte, et al.
Molecular Genetics & Genomic Medicine|August 9, 2021
Functional characterization of CDK10 and cyclin M truncated variants causing severe developmental disordersThomas Robert, Anne-Catherine Dock-Bregeon, Pierre Colas
Oncotarget|February 9, 2017
The awakening of the CDK10/Cyclin M protein kinaseVincent J Guen, Carly Gamble, Jacqueline A Lees, et al.
Pageof 4